相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy
Elke Martin et al.
TOXICOLOGY (2009)
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone
T. Simunek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes
Eugene A. Konorev et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Ultrastructural definition of apoptosis in heart failure
Eloisa Arbustini et al.
HEART FAILURE REVIEWS (2008)
Anthracycline cardiotoxicity: From bench to bedside
Luca Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo
Olga Popelova et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study
A. M. E. Bruynzeel et al.
BRITISH JOURNAL OF CANCER (2007)
Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Yi Lisa Lyu et al.
CANCER RESEARCH (2007)
Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice
Anna M. E. Bruynzeel et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity:: A study of salicylaldehyde isonicotinoyl hydrazone (SIH)
Martin Sterba et al.
TOXICOLOGY (2007)
Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis
Kendall B. Wallace
CARDIOVASCULAR TOXICOLOGY (2007)
Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?
Brian B. Hasinoff et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity
Martin Sterba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin
H. Kaiserova et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Anthracycline cardiotoxicity
Robin L. Jones et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Doxorubicin prevents endoplasmic reticulum stress-induced apoptosis
SJ Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies
KA Wouters et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
SIH -: a novel lipophilic iron chelator -: protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death
T Simunek et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits
T Simunek et al.
BIOMETALS (2005)
Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits
T Simünek et al.
PHARMACOLOGICAL RESEARCH (2005)
Dexrazoxane - A review of its use for cardioprotection during anthracycline chemotherapy
RS Cvetkokic et al.
DRUGS (2005)
Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes
CC Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats
YM Jang et al.
FEBS LETTERS (2004)
Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents
T Simunek et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Doxorubicin-induced cardiac mitochondrionopathy
KB Wallace
PHARMACOLOGY & TOXICOLOGY (2003)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Doxorubicin-induced persistent oxidative stress to cardiac myocytes
SY Zhou et al.
TOXICOLOGY LETTERS (2001)
Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats
JP Bertinchant et al.
CLINICA CHIMICA ACTA (2000)
Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative
J Pilz et al.
JOURNAL OF CHROMATOGRAPHY B (2000)
Apoptosis in rat cardiac myocytes induced by Fas ligand: Priming for Fas-mediated apoptosis with doxorubicin
M Yamaoka et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Molecular basis of anthracycline-induced cardiotoxicity and its prevention
MS Horenstein et al.
MOLECULAR GENETICS AND METABOLISM (2000)
The cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity
JC Kwok et al.
REDOX REPORT (2000)
分享论文
